Home » Topics » Regulatory » Patents

Patents
RSS

IRL patents cortical cathecolaminergic neurotransmission modulators

Dec. 16, 2016

Chong Kun Dang Holdings divulges new histone deacetylase inhibitors

Dec. 15, 2016

Principia Biopharma patents new FGFR inhibitors

Dec. 15, 2016

Merck & Co. discovers soluble guanylate cyclase activators

Dec. 15, 2016

Harvard and Evotec divulge novel bacterial glycosyl transferase inhibitors

Dec. 15, 2016

TSRI, Icahn School of Medicine and UPenn patent nAChR modulators

Dec. 15, 2016

Shanghai Institute Materia Medica develops tyrosine kinase inhibitors

Dec. 15, 2016

Chinese scientists patent FGFR inhibitors

Dec. 14, 2016

Idenix Pharmaceuticals and Southern Research Institute disclose nucleoside derivatives

Dec. 14, 2016

Novogen presents TMP3 inhibitors

Dec. 14, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...